Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CEFILONE: Fimasartan vs Losartan in Hypertension
NCT02958631Phase 4Unknown
- Sponsor
- Hallym University Chuncheon Sacred Heart Hospital
- Start
- Nov 2014
- Primary completion
- Dec 2016
- Modality
- Small Molecules
01
Overview
Phase 4, randomised trial of fimasartan in hypertension (HTN) (2 arms), sponsored by Hallym University Chuncheon Sacred Heart Hospital. Primary endpoint: Blood Pressure Lowering Effect through 24 ABPM at 24 hour. Status: unknown.
02
Drugs
fimasartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02958631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02958631.